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by Ezaki et al.11] and Takagi et al.12 ).
Fermentation
The IFM0406 strain was an isolate from a patient of lung nocardiosis and had been kept in our center. This strain has been deposited at the National Institute of The media and procedures used for culture and physiological characteristics of the IFM 0406 strain were those of described by Goodfellow7), Schaal8) and Mikami and Yazawa9) .
Cell Chemistry
The IFM 0406 strain was grown in brain heart infusion (BHI medium, Difco) broth containing 1% glucose at 32°C for 7 days on a rotary shaker. The cultures were killed by 1 % (final concentration) of formaldehyde. The washed and packed mycelial cakes were freeze-dried as a whole-cell preparation. Cell walls were prepared as described by Schaal8). For the determination of diaminopimelic isomers (DAP) and sugar components, cell wall hydrolysates were developed by thin layer chromatography (TLC) plate and the type of DAPand sugar components weredeterminedin comparisonwith those of standard compounds8). For the determination of mycolic acid patterns, a mixture of methanol-toluene-sulfuric acid (30 : 15 : 1, v/v) were added to the dried cells. The methanolysates were applied to TLCplates and the mycolic acid patterns were determined8). Menaquinone fractions were purified by preparative thin layer chromatography (Pre-TLC). The fraction was monitored by HPLCusing following conditions: column, Lichro cart RP-18 (Merck, 4.6x 150mm), flow rate; 1 ml/minute, detection; UV235 nm, mobile phase; methanol : iso-prop&nol (2 : 1). Components were identified by comparison of retention time with those of standard mixtures1 0).
DNA Base Composition and DNA-DNAHybridization
Level of DNAreassociation were determined by using photobiotin (Vectra Laboratories, Inc., Burlingame,
Calf.) labeling probes in microplate wells as described 1037 Aloopful of the slant culture of the IFM 0406 strain was inoculated into a 500-ml Erlenmeyer flask containing 150ml of 1%glucose BHI seed medium. The seed culture was transferred to 20 liters of a production medium contained of glycerol 2%, polypeton 1%, meat extract 0.5%, Adekanol (Asahi Denka Co., Ltd.) 0.1%, pH 8.0 before sterilization.
Fermentation was carried out at 30°C for 7 days under aeration of 15 liters/minute and agitation at 200 rpm.
MLRTest
The immunosuppressive activity of the compoundwas assessed with two-way mixed lymphocyte reactions as described by McAlpine et al.13) . Briefly, BALB/c and C57BL/6 mice (female, 17~18g) were sacrificed and spleens were aseptically removed. Spleens were homogenized and contaminating erythrocytes were lysed by suspension in EDTA-ammonium chloride solution. The BALB/c and C57BL/6 spleen cell suspensions were diluted to 2.5 xlO6 viable cells/ml and pooled, before mixed cultures were established in 96-well microtiter plates. After 72 hours incubations at 37°C in a humidified atmosphere of 5% CO2 in air, increases in proliferation were assessed by cellular uptake of tritiated thymidine.
The IC50 values of immunosuppressivecompoundwere graphically determined after incorporation of thymidine was corrected for incorporation in unstimulated cultures and normalized as a percent of incorporation in stimulated cultures. Ascomycin (FR-900520)14) and cyclosporin A1 5) were used as reference immunsuppressive drugs.
Biological Activity Antimicrobial activities were determined by microbroth dilution method using BHI broth (Difco).
Cytotoxic activities
were also determined by the method described in our previous paper16).
Results and Discussion
Taxonomic Studies
The isolates contained the rneso-isomev of DAP,as well as galactose and arabinose. These results indicated that the IFM 0406 strain belongs to chemotype IV in the classification system of Lechevalier and Lechevalier1 7). Whenthe mycolic acids of the isolate were determined by TLCpatterns and HPLCprofiles, it was found that they contained mycolic acid type of Nocardia or Rhodococcus18). Our studies on the menaquinone compositions of the isolate indicated that they have MK-8H4 (cycl.) as the major menaquinone composition and MK-8H2and MK-9H4as minor menaquinones.
IFM 0406 strain decomposed, casein, hypoxanthine and tyrosine, but did not decompose adenine and xanthine. The organisms also hydrolyzed urea after growth on Christensen urea agar at 27°C for 3 weeks. The strain could grow at 45°C on Sabouraud dextrose agar, and Na-citrate was utilized as a carbon source. /?-Lactamase production of IFM 0406 strain was con- was tested, this strain was found to show the similar susceptibility pattern against the first three drugs to that of the type species, but showed different susceptibility to kanamycin. Except for the failure to decompose urea and for the different susceptibility to kanamycin as shown in 
Fermentation
A typical time course of the brasilinolide A production is shown in Fig. 2 . The antibiotic production began at 25 hours and reached to maximumafter 70 hours incubation, coupled with the growth. The pH of culture broth increase until 20 to 25 hours after the inoculation and then decreased to pH 5.0. After 100 hours' incubation, the pH again began to increase and attain to 7.0 to 8.0 at 120 hours.
Isolation and Purification
The culture (20 liters) was killed by the addition of 2 volume of methanol and evaporated to the original volume. The filtrate was subjected to a Diaion HP-20 column (30x30cm) and washed with 2m NaCl (4 «-hexane, acetone determined as shown in Fig. 1 , and the structural studies were repoted6).
Antimicrobial and Antitumor Activities Brasilinolide A showed moderate antifungal activity against Aspergillus niger IFM 40406 and it's MICvalue was 3.13 /zg/ml (Table 4 ). The antibiotic was not active against any other bacteria and fungi tested at the concentration of 100//g/ml.
It is well-known that FK-506 andcyclosporinAshow antifungalactivity. Therefore, 
Cytotoxicity
Comparison of the toxicity of brasilinolide A with ascomycin and cyclosporin A are shown in Table 5 . When IC50 values were compared, brasilinolide A was less toxic than ascomycin and cyclosporin A against 9 tumor cell-lines tested. Generally cyclosporin A was more toxic
than ascomycin against the cells tested. Interestingly, intravenous administration of brasilinolide A showed no sign of toxicity in the dose of 500mg/kg in mice. It was reported that LD50 values ofFK-5062'14) and cyclosporin A15) were 25mg/kg and 107mg/kg in mice by the same administration route, respectively. In the present experiments, we used ascomycin (FK-90052) as one of the reference drugs. The structural difference between ascomycin and FK-506 are in their side chain, and the side chain in ascomycin is ethyl group instead of the allyl group in FK-506. Although it is reported that ascomycin is less toxic than FK-50614), our preliminary studies showed that cytotoxicity of FK-506 and ascomycin were similar. Detailed comparative studies in their toxicity are in progress in our laboratory.
Suppression of MLR The suppressive effect of various concentration of brasilinolide A, ascomycin and cyclosporin A on the mouse MLRare shown in Table 6 . The IC50 values (the concentration causing 50% inhibition) under the present conditions, were 0.625, 0.016 and 0.040/ig/ml, respectively. Although brasilinolide A was less effective than cyclosporin A and ascomycin, the antibiotic found to be less toxic against cultured cells as shown in Table 5 .
Comparison of the acute toxicity data of FK-506 and Therefore, brasilinolide A is considered worthy offurther evaluation as an immunotherapeutic agent.
